A registry for cardiovascular bio-imaging and multi-omics data
Official title: Dongzong Cardiovascular Bio-imaging Registry Study
Run by Jinling Hospital, China · NCT06894095 · Data updated 2026-11-12
This study is trying to collect and analyze different types of health data from adults who have had heart imaging to see how genetics and environment affect heart disease and find ways to prevent and manage it.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50000 (estimated) |
| Sponsor | Jinling Hospital, China Academic / other |
| Locations | 3 sites (Nanjing, Jiangsu and 2 other locations) |
| Status | Recruiting |
| Started | May 24, 2023 |
| Main results expected | March 31, 2028 |
| Study ends | May 31, 2038 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT06894095 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who have undergone coronary CT angiography.
✕Probably not a fit
Patients with serious chronic kidney disease, liver dysfunction, or those unable to complete follow-up may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The DAILY project is a large-scale, multicenter initiative aimed at creating a comprehensive bio-imaging database that integrates various data types, including living environments, psychosocial assessments, advanced imaging, and multi-omics profiles. This observational study seeks to understand the complex interactions between genetic and environmental factors that influence cardiovascular diseases (CVD). By analyzing these multidimensional datasets, the project aims to identify critical intervention points for the prevention and management of CVD. The study includes participants aged 18 and older who have undergone coronary CT angiography and have provided informed consent.
Why it matters
Potential benefit: If successful, this project could lead to innovative strategies for preventing and managing cardiovascular diseases.
How similar studies have gone: While the integration of multi-omics and bio-imaging is a novel approach, similar studies have shown promise in understanding cardiovascular diseases.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged ≥18 years * Coronary CT angiography performed * Informed consent acquired Exclusion Criteria: * Unable to complete the follow-up * Serious chronic kidney disease (eGFR\< 30 ml/min/1.73 m2) * Serious liver disease or dysfunction (chronic active hepatitis and cirrhosis, or aspartate aminotransferase (AST) or alanine transaminase (ALT) \> 3 times the upper limit of normal) * Not appropriate to be tested due to birth planning, allergies, acute thyroid storm, etc. * Suspected or known infectious diseases, such as hepatitis B virus (HBV), human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), and Treponema pallidum (syphilis), etc.
Where it's running
-
Longjiang Zhang
Nanjing, Jiangsu, China Recruiting -
Longjiang Zhang
Suqian, Jiangsu, China Recruiting -
Longjiang Zhang
Zhenjiang, Jiangsu, China Recruiting
Study contacts
- Principal investigator: Longjiang Zhang, MD — Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
- Study coordinator: Longjiang Zhang, MD
- Email: kevinzhlj@163.com
- Phone: 13405833167
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Colchicine for preventing cardiovascular disease in adults with type 2 diabetes
A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.
-
Optimised Cardio-Renal Care for CKD and heart disease
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
-
Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients
This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.
-
One-stop photon-counting CT for patients after PCI
This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.